Semisynthetic aminoglycoside antibiotics: Development and enzymatic modifications

[1]  S. Mizuno,et al.  The novel enzymatic 3''-N-acetylation of arbekacin by an aminoglycoside 3-N-acetyltransferase of Streptomyces origin and the resulting activity. , 1998, The Journal of antibiotics.

[2]  T. Mikami,et al.  A newly recognized acetylated metabolite of arbekacin in arbekacin-resistant strains of methicillin-resistant Staphylococcus aureus. , 1998, Journal of Antimicrobial Chemotherapy.

[3]  S. Mizuno,et al.  Enzymatic 2'-N-acetylation of arbekacin and antibiotic activity of its product. , 1996, The Journal of antibiotics.

[4]  T. Takeuchi,et al.  Antibacterial activity and nephrotoxicity of two novel 2″-amino derivatives of arbekacin , 1996, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[5]  T. Kudo,et al.  Synthesis of 2''-amino-2''-deoxyarbekacin and its analogs having potent activity against methicillin-resistant Staphylococcus aureus. , 1994, The Journal of antibiotics.

[6]  T. Kudo,et al.  New 2''-amino derivatives of arbekacin, potent aminoglycoside antibiotics against methicillin-resistant Staphylococcus aureus. , 1993, The Journal of antibiotics.

[7]  P. Rather,et al.  Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. , 1993, Microbiological reviews.

[8]  S. Mitsuhashi,et al.  Structures of enzymatically modified products of arbekacin by methicillin-resistant. Staphylococcus aureus. , 1993, The Journal of antibiotics.

[9]  S. Mizuno,et al.  Mechanism of increased kanamycin-resistance generated by protoplast regeneration of Streptomyces griseus. I. Cloning of a gene segment directing a high level of an aminoglycoside 3-N-acetyltransferase activity. , 1988, The Journal of antibiotics.

[10]  K. Ubukata,et al.  Purification and characterization of aminoglycoside-modifying enzymes from Staphylococcus aureus and Staphylococcus epidermidis , 1984, Antimicrobial Agents and Chemotherapy.

[11]  H. Umezawa,et al.  A predominant role of amino groups in the antibacterial action of aminoglycosides: synthesis of hexa- and heptadeoxykanamycin derivatives. , 1983, The Journal of antibiotics.

[12]  H. Umezawa,et al.  Mechanisms of Resistance to Aminoglycoside Antibiotics , 1982 .

[13]  I. R. Hooper.  The Naturally Occurring Aminoglycoside Antibiotics , 1982 .

[14]  H. Umezawa,et al.  Chemical modification of 5,3',4'-trideoxykanamycin B. , 1981, The Journal of antibiotics.

[15]  J. Davies,et al.  Enzymatic Modification of Aminoglycoside Antibiotics: 3-N-Acetyltransferase with Broad Specificity that Determines Resistance to the Novel Aminoglycoside Apramycin , 1978, Antimicrobial Agents and Chemotherapy.

[16]  A. Cooper,et al.  The syntheses and biological properties of 1-N-(S-4-amino-2-hydroxybutyryl)-gentamicin B and 1-N-(S-3-amino-2-hydroxypropionyl)-gentamicin B. , 1978, The Journal of antibiotics.

[17]  J. Davies,et al.  Plasmid-determined resistance to antimicrobial agents. , 1978, Annual review of microbiology.

[18]  F. Goffic.  The resistance of S.aureus to aminoglycoside antibiotics and pristinamycins in France in 1976〜1977 , 1977 .

[19]  J. Duval,et al.  2″-O-Phosphorylation of Gentamicin Components by a Staphylococcus aureus Strain Carrying a Plasmid , 1977, Antimicrobial Agents and Chemotherapy.

[20]  J. Duval,et al.  New Plasmid-Mediated Nucleotidylation of Aminoglycoside Antibiotics in Staphylococcus aureus , 1976, Antimicrobial Agents and Chemotherapy.

[21]  F. Kayser,et al.  Tobramycin adenylyltransferase: a new aminoglycoside-inactivating enzyme from Staphylococcus epidermidis. , 1976, The Journal of infectious diseases.

[22]  J. Davies,et al.  Enzymatic Modification of Aminoglycoside Antibiotics: a New 6′-N-Acetylating Enzyme from a Pseudomonas aeruginosa Isolate , 1976, Antimicrobial Agents and Chemotherapy.

[23]  J. Davies,et al.  Enzymatic Modification of Aminoglycoside Antibiotics: a New 3-N-Acetylating Enzyme from a Pseudomonas aeruginosa Isolate , 1976, Antimicrobial Agents and Chemotherapy.

[24]  J. J. Wright.  Synthesis of 1-N-ethylsisomicin: a broad-spectrum semisynthetic aminoglycoside antibiotic , 1976 .

[25]  H. Umezawa,et al.  [11] Ion-exchange chromatography of aminoglycoside antibiotics , 1975 .

[26]  S. Mitsuhashi.  Proposal for a Rational Nomenclature for Phenotype, Genotype and Aminoglycoside-Aminocyclitol Modifying Enzymes , 1975 .

[27]  H. Umezawa.  Biochemical mechanism of resistance to aminoglycosidic antibiotics. , 1974, Advances in carbohydrate chemistry and biochemistry.

[28]  S. Umezawa.  Structures and syntheses of aminoglycoside antibiotics. , 1974, Advances in carbohydrate chemistry and biochemistry.

[29]  H. Umezawa,et al.  SYNTHESES OF (S)-4-AMINO-2-HYDROXYBUTYRYL DERIVATIVES OF 3', 4'-DIDEOXYKANAMYCIN B AND THEIR ANTIBACTERIAL ACTIVITIES , 1973 .

[30]  H. Umezawa,et al.  Letter: Syntheses of 1-n-(S)-4-amino-2-hydroxybutyryl)-kanamycin B and -3', 4'-dideoxykanamycin B active against kanamycin-resistant bacteria. , 1973, The Journal of antibiotics.

[31]  H. Kawaguchi,et al.  BB-K 8, a new semisynthetic aminoglycoside antibiotic. , 1972, The Journal of antibiotics.

[32]  H. Umezawa,et al.  Studies on Aminosugars. XXIX. The Synthesis of 3′-O-Methylkanamycin , 1972 .

[33]  H. Naganawa,et al.  Structure determinations of enzymatically phosphorylated products of aminoglycosidic antibiotics by proton magnetic resonance. , 1971, The Journal of antibiotics.

[34]  H. Umezawa,et al.  3',4'-dideoxy-kanamycin B active against kanamycin-resistant Escherichia coli and Pseudomonas aeruginosa. , 1971, The Journal of antibiotics.

[35]  H. Umezawa,et al.  Synthesis of 3'-deoxykanamycin effective against kanamycin-resistant Escherichia coli and Pseudomonas aeruginosa. , 1971, The Journal of antibiotics.

[36]  P. W. Woo,et al.  Butirosins A and B, aminoglycoside antibiotics. III. Structures , 1971 .

[37]  三橋 進.  Drug action and drug resistance in bacteria , 1971 .

[38]  M. Okanishi,et al.  Studies on adenylylstreptomycin, a product of streptomycin inactivation by E. coli carrying the R-factor. , 1968, The Journal of antibiotics.

[39]  J. Davies,et al.  Enzymatic Inactivation of Streptomycin by R Factor-resistant Escherichia coli , 1968, Nature.

[40]  H. Umezawa,et al.  Chemical derivation of antibiotics active against resistant bacteria. , 1968, Japanese journal of medical science & biology.

[41]  M. Okanishi,et al.  Isolation of kanamycin and paromamine inactivated by E. coli carrying R factor. , 1968, The Journal of antibiotics.

[42]  H. Umezawa,et al.  Phosphorylation and inactivation of aminoglycosidic antibiotics by E. coli carrying R factor. , 1968, The Journal of antibiotics.

[43]  M. Okanishi,et al.  Adenylylstreptomycin, a product of streptomycin inactivated by E. coli carrying R factor. , 1968, The Journal of antibiotics.

[44]  S. Mitsuhashi,et al.  Phosphorylative inactivation of aminoglycosidic antibiotics by Escherichia coli carrying R factor. , 1967, Science.

[45]  M. Okanishi,et al.  Studies on inactivation of kanamycin and resistances of E. coli. , 1967, The Journal of antibiotics.

[46]  M. Okanishi,et al.  Isolation and structure of kanamycin inactivated by a cell free system of kanamycin-resistant E. coli. , 1967, The Journal of antibiotics.

[47]  Yoshiaki Suzuki,et al.  Chloramphenicol-, Dihydrostreptomycin-, and Kanamycin-Inactivating Enzymes from Multiple Drug-Resistant Escherichia coli Carrying Episome ‘R’ , 1965, Nature.

[48]  K. Nitta,et al.  Production and isolation of a new antibiotic: kanamycin. , 1957, The Journal of antibiotics.

[49]  S. Waksman,et al.  Neomycin, a New Antibiotic Active against Streptomycin-Resistant Bacteria, including Tuberculosis Organisms. , 1949, Science.

[50]  H. Umezawa,et al.  CLASSIFICATION OF ANTIBIOTIC STRAINS OF STREPTOMYCES AND THEIR ANTIBIOTIC SUBSTANCES ON THE BASIS OF THEIR ANTIBACTERIAL SPECTRA , 1948 .